Nimotuzumab enhances the sensitivity of non-small cell lung cancer cells to tumor necrosis factor-α by inhibiting the nuclear factor-кB signaling pathway-Reference-Cited by-同舟云学术

Nimotuzumab enhances the sensitivity of non-small cell lung cancer cells to tumor necrosis factor-α by inhibiting the nuclear factor-кB signaling pathway

Published:2018-02-12 Issue: Volume: Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Zhu Jing¹,Xin Ying¹,Liu Xiaoliang²,Wang Ying¹,Liu Ying¹

Affiliation:

1. Department of Thoracic Oncology, Cancer Hospital of Jilin Province, Changchun, Jilin 130012, P.R. China

2. Department of Blood Cancer, The First Affiliated Hospital of Jilin University, Changchun, Jilin 130021, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An EGCG Derivative in Combination with Nimotuzumab for the Treatment of Wild-Type EGFR NSCLC;International Journal of Molecular Sciences;2023-09-13

2. Immunohistochemical Detection of TNF-α and IFN-γ Expressions in the Lungs of Sheep with Pulmonary Adenocarcinomas;Acta Veterinaria Eurasia;2022-09-19

3. Etanercept and Infliximab, Two Tumor Necrosis Factor-α (TNF-α) Inhibitors With Different Action Profiles: An In vitro and In Vivo Study in the Context of Reviewed Therapeutic Applications;Biointerface Research in Applied Chemistry;2022-09-11

4. Features of cytokine production in tumor associated with metastasis and basal cell hyperplasia of bronchial epithelium in non-small cell lung cancer;Genes & Cells;2021-06-15

5. The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment;Frontiers in Immunology;2021-04-27